Skip to main content

MJFF Publications

901 - 910 of 7616 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Revisiting levodopa for advanced Parkinson's disease.
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Roc, the G-domain of the Parkinson’s disease-associated protein LRRK2
    Journal Name: Trends in Biochemical Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.tibs.2022.06.009
    Citation Count: 5
  • RESTRICTED
    Title: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8
    Best OA location URL:
    Citation Count: 30
  • RESTRICTED
    Title: Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-022-00863-y
    Citation Count: 14
  • RESTRICTED
    Title: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896
    Citation Count: 8
  • RESTRICTED
    Title: The plight of loneliness in Parkinson's disease: New opportunities
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.029
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649
    Best OA location URL:
    Citation Count: 5
  • RESTRICTED
    Title: Volitional Control of Brain Motor Activity and Its Therapeutic Potential
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.007
    Citation Count: 6
  • RESTRICTED
    Title: Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
    Journal Name: International Neurourology Journal
    Publisher: Korean Continence Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.5213/inj.2222206.103
    Citation Count: 5
  • RESTRICTED
    Title: The Existential Essentialism in Tremor Nosology − 7 Pitfalls, 2 Remedies, and a Path Ahead
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13622
    Citation Count: 3
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.